PIK3CD and acute myeloid leukemia: As to other components of this signaling pathway, p85α PI3K was demonstrated to be involved in oncogenic c-Kit-induced transformation in AML and systemic mastocytosis, in a model where p85α PI3K expression was disrupted in HSCs and mast cell progenitors.